Research Projects- Environmental Health Sciences
Active Research
Learn about our featured COHSE- EHS Faculty Research at the University of Michigan
Stuart Batterman
Community Action to Promote Healthy Environments
Co/Principal Investigator: Stuart Batterman, PhD
NIEHS: R01
1/1/21-10/31/25
ABSTRACT
The overarching goals of the Community Action to Promote Healthy Environments (CAPHE) partnership, established in 2014, are to: (1) develop new knowledge on local community-prioritized air pollutants; (2) implement components of our scientifically-grounded community-informed Public Health Action Plan (PHAP) to reduce exposure and improve health; (3) expand community engagement in environmental health research and action; and (4) evaluate the process and impact of these collaborative efforts. Building on long-standing community-based participatory research (CBPR) partnerships engaging community-based organizations (CBOs), local and state governments, and academic partners, CAPHE conducted collaborative research, training, education and outreach on air pollution, an environmental priority of the Detroit community, and health impacts. We documented air pollutant levels, sources and distribution, quantified health impacts and inequities, identified mitigation strategies, and projected health benefits of selected strategies. Our PHAP detailed 25 scientifically based community-prioritized recommendations and action strategies to reduce pollutant exposure and adverse health effects. CAPHE partners, leading advocates for air quality and health in Detroit, are working to implement prioritized recommendations. This renewal application, CAPHE: Advancing Air Quality and Health, will substantially expand the scope and impact of our successful research-to-action partnership through four aims: (1) increase knowledge of environmental exposures and associated health impacts by establishing a community-based ambient monitoring network and data portal for key air pollutants (PM2.5, PM10, organic carbon, black carbon); (2) improve indoor environmental quality (IEQ) in schools and other child-serving organizations located near major roads and industrial sites with high levels of cumulative risk, using advanced air filtration practices and other strategies; (3) engage youth, educators, parents, CBOs and business leaders in air quality research and translation, increasing environmental health literacy, access to resources, and skills working with decision makers; and (4) increase effectiveness, engagement and impact of actions in Specific Aims 1-3 using ongoing formative process and impact/outcome evaluation. The proposed project will be implemented by a team that includes five Detroit CBOs with extensive records of environmental leadership, five academic researchers with complementary expertise, and experienced state and local government partners. CAPHE has a strong history of CBPR, experience in air quality monitoring, data interpretation, and impact analysis (Aim 1); IEQ improvements (Aim 2); community engagement and translation of research to action (Aim 3); and process and impact evaluation to maximize engagement and effectiveness (Aim 4). This research-to-action proposal addresses community priorities of air quality and children’s health using linked, collaborative activities that will reduce exposure and adverse health effects and support sustained engagement. Results have will be useful for communities globally that experience high cumulative risk.
Developing novel strategies for personalized treatment and prevention of ALS:
Co/Principal Investigator: Stuart Batterman, PhD
NINDS: R01
9/30/21-6/30/25
ABSTRACT
Genetic heritability incompletely explains amyotrophic lateral sclerosis (ALS), and the pace of ALS genetic dis- coveries has slowed, meaning entirely new research directions are needed to unravel disease mechanisms and identify therapies. Our goal is to understand, cure, and prevent ALS. Our overall approach is to identify the intersection of exposures, genomics, epigenomics, transcriptomics, metabolomics, and inflammation on ALS. Our rationale is that prior environmental risk scores (ERS) based on even crude plasma measures of limited classes of pollutants associate with a 7-fold increase in ALS risk and 2-fold decrease in survival, therefore a detailed understanding of the exposome with other omics can immediately provide new, much needed strate- gies for both ALS treatment and prevention. We propose 3 aims: 1) comprehensively assess environmental exposures and polygenic factors in ALS versus control subjects to identify synergistic environment-polygenic associations that increase ALS risk; 2) define exposome signatures in the ALS epigenome, transcriptome, and metabolome; and 3) determine how environmental exposures alter ALS immune profiles and identify drug tar- gets. First, we account for the complex exposure data from self-reports, geospatial analysis, and biospecimens using component-ERS (cERS) for specific exposure types (e.g. pesticides, metals, air pollution) and a poly- ERS for combined exposures. We account for genetic risk using polygenic risk scores (PRS) and C9ORF72 status. We will build ALS risk and prediction models based on ERS and PRS. Next, using cERS, poly-ERS, and PRS, we determine the environmental signature on the DNA methylome, mRNA and microRNA, to identify exposures that associate with differentially expressed genes and target pathways. Expression quantitative trait loci (eQTL) analyses will define the relative contribution of polymorphisms vs exposures on gene expression. High resolution untargeted metabolomics will reveal the environmental signature of the ALS metabolome and identify new toxicants. All datasets will be integrated using pan-omics techniques to identify gene-metabolite networks that are disease targets. Finally, we will classify immune profiles that associate with cERS and poly- ERS to identify therapeutic targets using existing FDA approved drugs. Our proposal is highly innovative; it de- fines for each patient, (i) their exposome, summarized with cERS/poly-ERS; (ii) their genome summarized by PRS and its association with ERS to understand the combined gene/environment risk; (iii) their multi-omic en- vironmental signatures from the epigenome, transcriptome, metabolome, and inflammasome; (iv) their dysreg- ulated pathways, ranked by their association to ALS risk and progression to identify personalized mechanism- based drug-targets; and (v) ALS prediction models and preventative strategies via risk factor modification. Our parallel, multi-omics approach is significantly faster than serial, single-toxicant/omic approaches, and its inte- grated nature captures the full spectrum of omics intersections, accelerating scientific discovery. We will make significant strides in finding completely new therapeutic targets and public health preventative strategies.
Environmental Toxicology and Epidemiology Pre- and Post-Doctoral Research
Principal Investigator: Stuart Batterman, PhD
NIEHS: T32 Training Program
7/1/79-6/30/25
ABSTRACT
Exposure Assessment Core
Principal Investigator: Stuart Batterman, PhD
NIEHS: P30
4/15/11-3/31/27
ABSTRACT
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
Principal Investigator: Stuart Batterman, PhD
NIEHS: R01
1/1/20-10/31/24
ABSTRACT
Michigan-Ohio Occupational Research Education (MOORE) Program
Principal Investigator: Stuart Batterman, PhD
NIEHS: R25
9/1/21-8/31/26
ABSTRACT